Psychological intervention and counseling to reduce symptoms of prolonged grief disorder

The effect of cognitive-behavioral intervention in reducing fear of COVID-19 symptoms, anxiety, depression, stress and improving the quality of life in people suffering from prolonged grief disorder due to the COVID-19

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20230309057660N1

Enrollment

Registered

2023-04-19

Start date

2023-04-21

Completion date

Unknown

Last updated

2023-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

prolonged grief disorder.

Interventions

Intervention 1: Intervention group: Intervention group: The cognitive-behavioral intervention in this study is described as follows: In the first session, the participants are greeted and the cognitiv

Eligibility

Sex/Gender

All

Age

18 Years to 64 Years

Inclusion criteria

Inclusion criteria: Being within the age range of 18 to 65 years old Diagnosis of COVID-19 in an individual and the person is in the post-treatment recovery phase and also suffers from prolonged grief disorder Willingness to participate in the project and obtaining informed consent

Exclusion criteria

Exclusion criteria: Severe physical problems or visible organ impairment Patients with major depressive disorder, psychosis, or major psychiatric disorders were not included in the study and only initial drug treatments were performed for them

Design outcomes

Primary

Measure	Time frame
The primary outcome variable in this study is prolonged grief resulting from COVID-19. Timepoint: Assessment will be conducted in two stages, including prior to the start of cognitive-behavioral intervention, and one month after the final session of the intervention. Method of measurement: Using the Structured Clinical Interview for DSM Disorders (SCID).	—

Secondary

Measure	Time frame
Fear of COVID-19 Scale Score in Individuals with COVID-19-Related Prolonged Grief Disorder. Timepoint: Assessment will be conducted in two stages, including prior to the start of cognitive-behavioral intervention, and one month after the final session of the intervention. Method of measurement: Fear of COVID-19 Scale.;Depression scores in individuals with prolonged grief disorder due to COVID-19. Timepoint: Assessment will be conducted in two stages, including prior to the start of cognitive-behavioral intervention, and one month after the final session of the intervention. Method of measurement: Using the Depression-Anxiety-Stress Scale (DASS-21) questionnaire.;Quality of life score in individuals with prolonged grief disorder due to COVID-19. Timepoint: Assessment will be conducted in two stages, including prior to the start of cognitive-behavioral intervention, and one month after the final session of the intervention. Method of measurement: Using the WHOQOL-BREF questionnaire.;Anxiety scores in individuals with prolonged grief disorder due to COVID-19. Timepoint: Assessment will be conducted in two stages, including prior to the start of cognitive-behavioral intervention, and one month after the final session of the intervention. Method of measurement: Using the Depression-Anxiety-Stress Scale (DASS-21) questionnaire.;Stress scores in individuals with prolonged grief disorder due to COVID-19. Timepoint: Assessment will be conducted in two stages, including prior to the start of cognitive-behavioral intervention, and one month after the final session of the intervention. Method of measurement: Using the Depression-Anxiety-Stress Scale (DASS-21) questionnaire.	—

Measure

Time frame

Fear of COVID-19 Scale Score in Individuals with COVID-19-Related Prolonged Grief Disorder. Timepoint: Assessment will be conducted in two stages, including prior to the start of cognitive-behavioral intervention, and one month after the final session of the intervention. Method of measurement: Fear of COVID-19 Scale.;Depression scores in individuals with prolonged grief disorder due to COVID-19. Timepoint: Assessment will be conducted in two stages, including prior to the start of cognitive-behavioral intervention, and one month after the final session of the intervention. Method of measurement: Using the Depression-Anxiety-Stress Scale (DASS-21) questionnaire.;Quality of life score in individuals with prolonged grief disorder due to COVID-19. Timepoint: Assessment will be conducted in two stages, including prior to the start of cognitive-behavioral intervention, and one month after the final session of the intervention. Method of measurement: Using the WHOQOL-BREF questionnaire.;Anxiety scores in individuals with prolonged grief disorder due to COVID-19. Timepoint: Assessment will be conducted in two stages, including prior to the start of cognitive-behavioral intervention, and one month after the final session of the intervention. Method of measurement: Using the Depression-Anxiety-Stress Scale (DASS-21) questionnaire.;Stress scores in individuals with prolonged grief disorder due to COVID-19. Timepoint: Assessment will be conducted in two stages, including prior to the start of cognitive-behavioral intervention, and one month after the final session of the intervention. Method of measurement: Using the Depression-Anxiety-Stress Scale (DASS-21) questionnaire.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSeyed salman Alavi

Tehran University of Medical Sciences

ssasi1979@gmail.com+98 21 5541 3540

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026